LINC02304

Across TCGA pan-cancer cohorts, LINC02304 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated LINC02304 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher LINC02304 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02304 expression acts as an unfavorable survival marker, although some lineages such as OV show a favorable association.

ACC, STAD, and OV are the cancer types where LINC02304 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	All	0.114	0.892	<.001	72	view →
STAD	DFS	Tertile	All	0.482	0.739	.003	66	view →
OV	DFS	Tertile	All	0.562	0.152	.014	48	view →
LGG	OS	Tertile	All	0.504	0.819	<.001	42	view →
PRAD	OS	Tertile	All	0.540	0.990	<.001	36	view →
READ	DFS	Tertile	All	0.111	0.799	.001	24	view →
KIRC	DFS	Tertile	IV	0.307	0.612	.045	18	view →
BLCA	OS	Tertile	IV	0.242	0.602	.037	18	view →
LIHC	OS	Tertile	All	0.144	0.704	.016	9	view →
BRCA	OS	Tertile	All	0.250	0.581	.040	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

LINC02304–ACC (OS)

Open the ACC breakdown →